A disproportionality analysis of CDK4/6 inhibitors in the FDA Adverse Event Reporting System (FAERS)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A disproportionality analysis of CDK4/6 inhibitors in the FDA Adverse Event Reporting System (FAERS)

Published:2024-08-05 Issue: Volume: Page:1-9
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Peng Yuan¹²,Zhou Yuying³,Zhou Xuanyi²,Jia Xu¹,Zhong Yan⁴

Affiliation:

1. Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

2. School of Pharmacy, North Sichuan Medical College, Nanchong, Sichuan, China

3. The First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu, China

4. Department of Pharmacy, Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region (Hospital. C. T), Chengdu, Sichuan, China

Funder

the Chengdu Municipal Health Commission 2022 Chengdu Medical Research Topic

the Research Project of the Science and Technology Development Program of Affiliated Hospital of North Sichuan Medical College

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2387323

Reference45 articles.

1. CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective

2. A pharmacokinetic evaluation of alpelisib for the treatment of HR+, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer

3. Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification

4. Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications

5. Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP